BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8722718)

  • 1. Determining factors for the outcome of peripheral blood progenitor cells harvests.
    Keung YK; Cobos E; Dunn D; Park M; Dixon S; Wu K; Park CH
    J Clin Apher; 1996; 11(1):23-6. PubMed ID: 8722718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mobilization of peripheral blood progenitor cells (PBPC) through a combination of chemotherapy and G-CSF in breast cancer patients and a possibility of unprocessed whole blood collection.
    Vanásek J; Filip S; Medková V; Bláha M; Mericka P; Volenec K
    Bone Marrow Transplant; 1998 Jan; 21(2):123-6. PubMed ID: 9489627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mobilization of peripheral blood progenitor cells by disease-specific chemotherapy in patients with soft tissue sarcoma.
    Schwella N; Rick O; Meyer O; Löffel J; Schleicher J; Serke S; Huhn D; Riess H
    Bone Marrow Transplant; 1998 May; 21(9):863-8. PubMed ID: 9613776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
    Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
    Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The number of circulating CD34+ blood cells predicts the colony-forming capacity of leukapheresis products in children.
    Leibundgut K; von Rohr A; Brülhart K; Hirt A; Ischi E; Jeanneret C; Muff J; Ridolfi-Lüthy A; Wagner HP; Tobler A
    Bone Marrow Transplant; 1995 Jan; 15(1):25-31. PubMed ID: 7538000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase of mobilized CD34-positive peripheral blood progenitor cells in patients with Hodgkin's disease, non-Hodgkin's lymphoma, and cancer of the testis.
    Zeller W; Gutensohn K; Stockschläder M; Dierlamm J; Kröger N; Koehne G; Hummel K; Kabisch H; Weh HJ; Kühnl P; Hossfeld DK; Zander AR
    Bone Marrow Transplant; 1996 May; 17(5):709-13. PubMed ID: 8733686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The median daily increment of leukocytes during hematopoietic recovery reflects the myeloid progenitor cell yield during leukapheresis in children.
    Emminger W; Emminger-Schmidmeier W; Höcker P; Gerhartl C; Kundi M; Gadner H
    Bone Marrow Transplant; 1990 Jun; 5(6):419-24. PubMed ID: 2369682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of CD34+ cell yield in peripheral blood progenitor cell product with the pre-leukapheresis cell counts in peripheral blood.
    Sawant RB; Rajadhyaksha SB
    J Assoc Physicians India; 2005 Dec; 53():1031-5. PubMed ID: 16572958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields.
    Sautois B; Fraipont V; Baudoux E; Fassotte MF; Hermanne JP; Jérusalem G; Bours V; Bosquée L; Schaaf-Lafontaine N; Paulus JM; Sondag D; Fillet G; Beguin Y
    Haematologica; 1999 Apr; 84(4):342-9. PubMed ID: 10190949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.
    Suzuya H; Watanabe T; Nakagawa R; Watanabe H; Okamoto Y; Onishi T; Abe T; Kawano Y; Kagami S; Takaue Y
    Vox Sang; 2005 Nov; 89(4):229-35. PubMed ID: 16262756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease in tumor cell contamination and progenitor cell yield in leukapheresis products after consecutive cycles of chemotherapy for breast cancer treatment.
    Glück S; Ross AA; Layton TJ; Ostrander AB; Goldstein LC; Porter K; Ho AD
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):316-23. PubMed ID: 9502299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of CD34+ cells mobilized into the peripheral blood predicts the yield of the leukapheresis product and can replace progenitor assays.
    D'Hondt L; André M; Guillaume T; Feyens AM; Humblet Y; Doyen C; Bosly A; Dromelet A; Chatelain B; Symann M
    Cytokines Cell Mol Ther; 1997 Mar; 3(1):21-6. PubMed ID: 9287240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience.
    Olivieri A; Offidani M; Montanari M; Ciniero L; Cantori I; Ombrosi L; Masia CM; Centurioni R; Mancini S; Brunori M; Leoni P
    Haematologica; 1998 Apr; 83(4):329-37. PubMed ID: 9592983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous bone marrow transplantation in non-Hodgkin's lymphomas: prediction of mononuclear cell yield in bone marrow harvests.
    Rinaldi C; Savignano C; Silvestri F; Geromin A; Cerno M; Fanin R; Biffoni F; Baccarani M
    Haematologica; 1995; 80(5):443-7. PubMed ID: 8566888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors affecting mobilization and peripheral blood stem cell (PBSC) collection using single apheresis (SA) for rescuing patients after high-dose chemotherapy (HD.CHE) in various malignancies.
    Koumakis G; Vassilomanolakis M; Hatzichristou H; Barbounis V; Filis J; Papanastasiou K; Moraki M; Kritsioti M; Plataniotis G; Stamatelou M; Efremidis AP
    Bone Marrow Transplant; 1996 Dec; 18(6):1065-72. PubMed ID: 8971374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
    Hassan HT; Zeller W; Stockschläder M; Krüger W; Hoffknecht MM; Zander AR
    Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
    Weaver CH; Schulman KA; Buckner CD
    Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell mobilization with G-CSF alone in breast cancer patients: higher progenitor cell yield by delivering divided doses (2 x 5 microg/kg) compared to a single dose (1 x 10 microg/kg).
    Kröger N; Zeller W; Hassan HT; Krüger W; Gutensohn K; Löliger C; Zander AR
    Bone Marrow Transplant; 1999 Jan; 23(2):125-9. PubMed ID: 10197796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mobilization strategies for the collection of peripheral blood progenitor cells: Results from a pilot study of delayed addition G-CSF following chemotherapy and review of the literature.
    Jacoub JF; Suryadevara U; Pereyra V; Colón D; Fontelonga A; Mackintosh FR; Hall SW; Ascensão JL
    Exp Hematol; 2006 Nov; 34(11):1443-50. PubMed ID: 17046563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.